Cold email campaign for clinical research — multi-channel campaign

{% spin %}{% variation %}Hello{% variation %}Dear{% variation %}Hi{% endspin %} {{firstName}}, {{linkedinnote}} The LinkedIn note begins with: “Your LinkedIn post about… Your LinkedIn profile shows that… Your interview OR your article OR your blog post… My colleague {{SalesRep}} told me about… … I’m delighted to get in touch with you.” --- → Audio message (sent 6 days after the LinkedIn connection request was accepted): Delighted to get in touch with you. My colleague {{SalesRep}} sent you an email regarding our biometrics services. Over 350 sponsors trust us as a specialist provider of data management and statistics, and I was wondering if you are currently overseeing any clinical trials? --- → Message mentioning colleagues’ names (sent 7 days later): Hello {{firstName}}, would it be best to contact your colleagues {{colleaguename1}} or {{colleaguename2}} to discuss biometric services related to the implementation of your clinical development programmes? --- → Follow-up message (sent 5 days later): {{firstName}}, I understand that it’s not certain whether you need help with trial design, data management or biostatistics at the moment. Please don’t hesitate to contact me if you’d like to know why sponsors prefer us to their former biometrics service provider. Best regards Other LinkedIn response templates → Sent manually if the prospect replies with an inconclusive message that interrupts the sequence {{firstName}}, my colleague {{SalesRep}} has sent you an email explaining why sponsors choose us for their clinical trial, data management, biostatistics and other services. [...] (full content available on request)

{% assign ampm = "now" | date: "%P" %}{% if ampm contains "am" %}Good morning{% else %}Good morning{% endif %} {{firstName}}, {{icebreaker}} Over 350 organisations trust us as their biometric partner for clinical trial design, data management and biostatistical services. Our clients were determined to optimise their clinical trial timelines and data processing workflows to improve their cost-effectiveness. They sought advice on data integrity and regulatory compliance. They also needed to ensure their data was ready for submission. [ClientCompanyName] handled the data management for our Phase I/II clinical trials, and I am very satisfied with this collaboration, says the clinical project manager at a Swiss biotechnology company. Is it worth providing a little more context during a brief phone call, or is that off-topic? Kind regards, {{signature}}

{% spin %}{% variation %}Hello{% variation %}Dear{% variation %}Hi{% endspin %} {{firstName}}, Would it be best to contact your colleague {{colleaguename1}} or {{colleaguename2}} regarding your clinical development programmes? I understand you’re busy, but I wouldn’t want to miss the opportunity to work with {{companyName}}. We’d like to see if it’s worth providing valuable support and helping to further {{company name}}’s mission. My to-do list below reminded me to write to you 😊 Have a great day {{signature}}

{% spin %}{% variation %}Hello{% variation %}Dear{% variation %}Hi{% endspin %} {{firstName}}, We understand that time and budget are limited, that regulatory hurdles are significant, and that the design of clinical trials is becoming increasingly complex. You and your colleagues will be impressed to see how our experts have helped our clients successfully complete their clinical trials. Would you have a little time this week to discuss this over the phone?

{% assign ampm = "now" | date: "%P" %}{% if ampm contains "am" %}Good morning{% else %}Good morning{% endif %} {{firstName}}, What do you think of my suggestion: finding out how pharmaceutical companies such as {{companyName}} have successfully completed their clinical trials by collecting data of the highest quality? Our clients consistently express their satisfaction at no longer having to deal with inexperienced staff. To prove this to you, we’d like to invite you to a [ProductName] lasting up to 5 hours to discuss {{companyname}}’s clinical development plan. This introductory call with our team of experts is 100% free. First of all, would you be interested in a virtual coffee to find out a bit more? {{signature}}

{% assign ampm = "now" | date: "%P" %}{% if ampm contains "am" %}Good morning{% else %}Good morning{% endif %} {{firstName}}, Our director [Director_Name] and I have been trying to get in touch with you. We thought you might be interested in finding out how our clients have solved Why do so many Phase III clinical trials fail? (webinar) Accelerated Authorisations (AA): not so fast! (white paper) The ultimate guide to clinical data management (eBook) Would it be possible to have a brief telephone chat? If you’re not interested, please let me know; that’s perfectly understandable. Kind regards, {{signature}} Objections: “We work with a CRO offering a full range of services (both a clinical CRO and a biometric CRO): Working with a dedicated biometric CRO ensures the highest quality for your clinical trial programmes in terms of data management and biostatistics. Background: Large CROs excel at managing clinical operations, such as patient recruitment and site monitoring. Biometric CROs ({{clientCompanyName}}), on the other hand, specialise in statistical analysis, data management and clinical data reporting. A partnership with both a clinical CRO and a biometric CRO gives you access to both these aspects. “We already have a partner”: “So you are already receiving the appropriate support from your clinical partner, a CRO specialising in biometrics, and if so, how is the collaboration with them going?”​ “Isn’t it worth exploring the other options available to find out what’s out there and at what cost?” “Have you noticed smooth communication between the clinical teams and those responsible for data management?” [...] (full content available on request)